The MedTech Conference 2025 (#MTC25) was a milestone moment for the global medtech community.

Hosted by AdvaMed, the world’s leading trade association representing medical device, diagnostics, and digital health companies, the event marked the organization’s 50th anniversary.

Over 3,700 leaders from 1,800 companies across 38 countries converged in San Diego, making it the largest MedTech Conference ever held in the U.S.

Scott Whitaker, AdvaMed President and CEO, captured the event’s energy, stating,

“No matter what I did—whether talking with attendees, experiencing hands-on demonstrations on the Medtech Campus, or learning from iconic speakers—I felt the enthusiasm and dedication of medtech innovators to make good health possible for as many people as possible.”

Here’s a recap of everything that happened at MTC25!

The central mandate: Accelerate, but with guardrails

The biggest theme of the conference was to develop and deploy AI at full speed with safety (fail-safe regulatory architecture) built in.

The industry’s next chapter depends on how quickly it can scale digital and AI innovation without losing sight of patient protection.

Michael “Mick” Farrell, Chairman & CEO of ResMed, captured that balance perfectly,

“The conversations here are driving deals, partnerships, inventions, and patient-focused breakthroughs.”

Behind that excitement was a shared understanding that progress must be fast, but never reckless.

AI in action: From insight to intervention in 24 hours

AI has moved from the lab to the core of medtech operations. It is no longer the experiment; it’s the engine.

In a session by Google Cloud, “The Era of Change: Transforming MedTech with AI,” experts showed how AI is streamlining safety reports and simplifying supply chain tasks from months to mere hours.

Teginder Singh, Global Head of Regulatory & Safety Operations at Google Cloud, summed it up:

“AI lets organizations take action within 24 hours. It’s an enabler to improve performance.”

This compresses the traditional months-long process into a single day, replacing a reactive guessing game with a predictive safeguard that slashes both patient risk and corporate liability.

That’s a whole new operating rhythm for medtech: fast, predictive, and safe.

Transforming surgery from art to science

The impact of digital tech extends directly into clinical practice. It is rewriting the playbook inside the OR.

Stryker CEO Kevin Lobo called this an “incredibly exciting era.” One where automation and standardized workflows are helping make surgery more consistent, accessible, and safer.

“We’re injecting better science into procedures that still have a little bit of art,” he said.

A powerful call to action

One of the most anticipated sessions of #MTC25 brought together Zimmer Biomet CEO Ivan Tornos and Arnold Schwarzenegger, the company’s Chief Movement Officer.

Their joint keynote “Bold Ideas. Bold Action.” set a high bar for the industry’s next chapter.

Tornos called on medtech leaders to act decisively and think fearlessly, reminding them that innovation means nothing without execution.

Schwarzenegger brought his trademark energy, urging the industry to champion prevention, personal responsibility, and public policy as core parts of global health progress.

Together, they delivered a message that resonated across the conference: 

The future of medtech belongs to those willing to move with both vision and purpose.

Regulators, standards, and the rulebook for AI

With great technological power comes the need for clear rules.

A major development highlighted at the conference was AdvaMed’s accreditation by the American National Standards Institute (ANSI) as a Standards Development Organisation (SDO).

This “stamp of approval” empowers the industry to lead the charge in creating consensus standards for AI, cybersecurity, and imaging.

A dedicated panel, featuring Peter Weems (AdvaMed), Diane Wurzburger (GE HealthCare), Scott Colburn (FDA/CDRH), Nick Decker (Roche), and Shan J. (Johnson & Johnson MedTech), reinforced the importance of these standards. They are essential for faster approvals, safer AI diagnostics, and device interoperability.

The presence of the FDA’s Scott Colburn confirmed the agency’s direct reliance on these industry-driven benchmarks.

Diversity and leadership

Diversity initiatives took centre stage at dedicated events.

At the MedTech Color breakfast, Dr Jennifer Jones-McMeans of Abbott Vascular outlined best practices for inclusive clinical trials.

The MedTechVets breakfast focused on enhancing veteran hiring and visibility across the industry.

The path forward requires diverse leadership. Mick Farrell summed it up well:

“Mixing perspectives and expertise is the fundamental fuel for superior strategy and breakthrough innovation.”

Celebrating excellence

he 2025 AdvaMed Lifetime Achievement Award was presented to Mike Mussallem, former CEO of Edwards Lifesciences,  for his “visionary leadership and unwavering commitment to improving patient lives.”

Spotlighting the next generation of innovators

From big players to rising stars, the exhibit floor buzzed with over 170 company presentations, showcasing technologies set to reshape how we diagnose, treat, and monitor health.

But all eyes were on the MedTech Innovator and Pitch & Pour competitions, where early-stage ingenuity took center stage.

In the inaugural Pitch & Pour startup competition, Cohesys CEO Michael Floros took home the top prize for BoneTape. It’s a flexible, resorbable surgical adhesive designed to repair facial fractures without the need for rigid metal plates or screws.

The MedTech Innovator Early-Stage Grand Prize, worth $350,000, went to Armor Medical Inc. for its breakthrough maternal health technology, the aRMOR device. This non-invasive, real-time monitor detects early hemorrhage in mothers, addressing one of the world’s leading causes of maternal mortality.

Four other pioneering startups each earned finalist awards ($25000) for their cutting-edge innovations:

• Luminoah: creator of a portable, connected enteral feeding system that makes nutrition therapy more mobile, discreet, and data-driven.
• Rivanna Medical: developer of AI-powered ultrasound guidance tools that make spinal anesthesia and trauma imaging safer and more precise.
• STENTiT: a Dutch company with a resorbable scaffold that helps arteries heal themselves after vascular interventions.
• SutureTech: innovator of RapidFix™, an all-suture soft-tissue fixation system that simplifies tendon and bone repair.

Meanwhile, Wavelet achieved a rare double victory. It won both the 2025 MedTech Innovator Execution Award and the Virginia Shimer Rybski Memorial Award for its non-invasive fetal EEG platform, which monitors fetal distress in real time.

Patient Pavilion: The patient perspective

The Patient Pavilion showcased patients whose lives have been transformed by medical technology, placing their powerful stories at the center of the industry dialogue.

Lance Bass, Grammy-nominated artist and Dexcom user, shared his personal journey of being diagnosed with Latent Autoimmune Diabetes in Adults (LADA). He highlighted how real-time glucose monitoring with Dexcom transformed his management of the complex condition.

Brooks Bell, a colon cancer survivor, shared how Olympus technology didn’t just diagnose her cancer. It prevented further growth by detecting and removing polyps during colonoscopy.

A global leader in medtech, Olympus Corporation specialises in developing endoscopes and other technologies for early diagnosis and minimally invasive therapy.

These stories reminded everyone why medtech innovation truly matters. It’s about lives changed, not just products launched.

Parting words

The 2025 MedTech conference proved that medtech is building healthcare’s future. AI, automation, inclusion, and patient voices all converged to shape a safer, smarter, more connected era of healthcare.

The record-breaking global gathering and the enthusiasm it contained “made it clear that medtech is the backbone of health care.”